PUTNAM INVESTMENTS LLC - UNITED THERAPEUTICS CORP DEL ownership

UNITED THERAPEUTICS CORP DEL's ticker is and the CUSIP is 91307CAF9. A total of 29 filers reported holding UNITED THERAPEUTICS CORP DEL in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.9%.

Quarter-by-quarter ownership
PUTNAM INVESTMENTS LLC ownership history of UNITED THERAPEUTICS CORP DEL
ValueSharesWeighting
Q2 2016$2,010,000
-4.8%
909,0000.0%0.01%0.0%
Q1 2016$2,112,000
-45.2%
909,000
-22.9%
0.01%
-44.4%
Q4 2015$3,854,000
+19.4%
1,179,0000.0%0.01%
+28.6%
Q3 2015$3,229,000
+8.4%
1,179,000
+45.0%
0.01%
+16.7%
Q2 2015$2,979,000
-19.3%
813,000
+31907.9%
0.01%
-45.5%
Q2 2013$3,692,0002,5400.01%
Other shareholders
UNITED THERAPEUTICS CORP DEL shareholders Q3 2013
NameSharesValueWeighting ↓
Sage Capital Management, LLC 2,500,000$4,245,0004.05%
WHITEBOX ADVISORS LLC 34,365,000$58,350,0003.08%
BASSO CAPITAL MANAGEMENT, L.P. 10,000,000$16,963,0002.96%
CAMDEN ASSET MANAGEMENT L P /CA 21,257,000$36,084,0002.17%
GRACE BROTHERS MANAGEMENT LLC 1,500,000$2,549,0002.17%
Ferox Capital Management LP 3,000,000$5,101,0001.96%
Castle Creek Arbitrage, LLC 20,700,000$35,185,0001.57%
Polar Asset Management Partners Inc. 20,000,000$34,012,0001.44%
SYMPHONY ASSET MANAGEMENT LLC 7,712,000$13,091,0001.33%
Verition Fund Management LLC 2,500,000$4,256,0000.64%
View complete list of UNITED THERAPEUTICS CORP DEL shareholders